Nanotechnological Advances in the Treatment of Epilepsy
Mohammed Tahir Ansari(University of Nottingham Malaysia Campus), Md. Abdullah Saeed Khan(University of Pittsburgh), M. Saquib Hasnain(University of Peshawar), Ola Asem Mahmoud Abdou Ali(University of Nottingham Malaysia Campus), Farheen Sami(University of Kuala Lumpur), Mohd. Farooq Shaikh(University of Mumbai)
Cited by 16
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175
Alcohol Use Disorder, Neurodegeneration, Alzheimer’s and Parkinson’s Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity
|Frontiers in Cellular Neuroscience|2020|160
Alcohol, Aggression, and Violence: From Public Health to Neuroscience
|Frontiers in Psychology|2021|144